
Study suggests Omicron has reinfection advantage as rich nations push vaccine boosters and Africa pleads for 1st shots
CBSN
Johannesburg — As data on real-world infections in South Africa, where the Omicron variant of the coronavirus was first identified, suggest the mutated virus has an increased ability to reinfect people who have already had COVID-19, the new strain is also highlighting inequalities in the global pandemic response.
A study published on Thursday as a pre-print, which is still awaiting peer review, found that Omicron is at least 2.4-times more likely to reinfect someone who's already had a COVID infection compared to the other variants that have been studied.
More Related News